Compare ImmunityBio Inc. Common Stock (IBRX) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while State Street SPDR Bloomberg High Yield Bond ETF trades at $92.75 (market cap $5.83B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and State Street SPDR Bloomberg High Yield Bond ETF for 60 Days on average.
| IBRX | JNK | |
|---|---|---|
Market Cap | $10.33B | $5.83B |
Volume | 11,745,198 | 4,722,904 |
Sector | Health | Fixed Income |
52-Week High | $11.55 | $98.02 |
52-Week Low | $1.98 | $92.30 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $10.79B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JNK trades at $92.76, down 0.13% with a bearish technical outlook indicated by moving averages. The ETF shows neutral oscillator signals with RSI at oversold levels. Recent corporate actions include consistent $0.53 dividend payments scheduled through October 2026. Market sentiment is influenced by rising bond yields and geopolitical tensions affecting high-yield bond markets.
The high-yield bond ETF faces headwinds from rising interest rates and inflation concerns, though consistent dividend payments provide income support. Key risks include further rate hikes and economic slowdown impacting junk bond performance. Institutional interest remains with recent position increases by asset managers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About State Street SPDR Bloomberg High Yield Bond ETF
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →
